Revisiting Notch in remyelination of multiple sclerosis lesions

Journal of Clinical Investigation

Volumn 119, Issue 1, 2009, Pages 10-13

  Brosnan, Celia F ^a   John, Gareth R ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTACTIN; GLYCOPROTEIN; KARYOPHERIN BETA; NOTCH1 RECEPTOR; ACYLTRANSFERASE; CONTACTINS; HTATIP2 PROTEIN, HUMAN; NERVE CELL ADHESION MOLECULE; TRANSCRIPTION FACTOR;

CELL NUCLEUS; CENTRAL NERVOUS SYSTEM; CHRONIC DISEASE; CYTOPLASM; MOLECULAR WEIGHT; MULTIPLE SCLEROSIS; NERVE CELL DIFFERENTIATION; NERVE FIBER; NONHUMAN; NOTE; OLIGODENDROGLIA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REMYELINIZATION; STEM CELL; CYTOLOGY; GENETICS; HUMAN; METABOLISM; MYELIN SHEATH; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REGENERATION; SIGNAL TRANSDUCTION;

ACETYLTRANSFERASES; CELL ADHESION MOLECULES, NEURONAL; HUMANS; MULTIPLE SCLEROSIS; MYELIN SHEATH; OLIGODENDROGLIA; RECEPTOR, NOTCH1; REGENERATION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 61749083654     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI37786     Document Type: Note

References (21)

1. Ludwin, S.K., and Raine, C.S. 2008. The neuropathology of MS. In Multiple sclerosis: a comprehensive text. C.S. Raine, H.F. McFarland, and R. Hohlfeld, editors. Saunders/Elsevier. New York, New York, USA. 151-177.
2. D'Souza, B., Miyamoto, A., and Weinmaster, G. 2008. The many facets of Notch ligands. Oncogene. 27:5148-5167.
3. Wang, S., et al. 1998. Notch receptor activation inhibits oligodendrocyte differentiation. Neuron. 21:63-75.
4. Popko, B. 2003. Notch Signaling: A rheostat regulating oligodendrocyte differentiation? Dev. Cell. 5:668-669.
5. Hu, Q.D., et al. 2003. F3/contactin acts as a functional ligand for Notch during oligodendrocyte maturation. Cell. 115:163-175.
6. Hu, Q.D., Ma, Q.-H., Gennarini, G., and Xiao, Z.C. 2006. Cross-talk between F3/Contactin and Notch at axoglial interface: A role in oligodendrocyte development. Dev. Neurosci. 28:25-33.
7. John, G.R., et al. 2002. Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat. Med. 8:1115-1121.
8. Nakahara, J., Kanekura, K., Nawa, M., Aiso, S., and Suzuki, N. 2009. Abnormal expression of TIP30 and arrested nucleocytoplasmic transport within oligodendrocyte precursor cells in multiple sclerosis. J. Clin. Invest. 119:169-181.
9. Padiath, Q.S., et al. 2006. Lamin B1 duplications cause autosomal dominant leukodystrophy. Nat. Genet. 38:1114-1123.
10. Schwankhaus, J.D., Katz, D.A., Eldridge, R., Schlesinger, S., and McFarland, H. 1994. Clinical and pathological features of an autosomal dominant, adult-onset leukodystrophy simulating chronic progressive multiple sclerosis. Arch. Neurol. 51:757-766.
11. King, F.W., and Shtivelman, E. 2004. Inhibition of nuclear import by the proapoptotic protein CC3. Mol. Cell. Biol. 24:7091-7101.
12. Lock, C., et al. 2002. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8:500-508.
13. El Omari, K., Bird, L.E., Nichols, C.E., Ren, J., and Stammers, D.K. 2005. Crystal structure of CC3 (TIP30): implications for its role as a tumor suppressor. J. Biol. Chem. 280:18229-18236.
14. Zhao, J., et al. 2008. Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma. Hepatology. 48:265-275.
15. Hur, E.M., et al. 2007. Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nat. Immunol. 8:74-83.
16. Ranscht, B. 1988. Sequence of contactin, a 130-kD glycoprotein concentrated in areas of interneuronal contact, defines a new member of the immunoglobulin supergene family in the nervous system. J. Cell Biol. 107:1561-1573.
17. Rios, J.C., et al. 2000. Contactin-associated protein (Caspr) and contactin form a complex that is targeted to the paranodal junctions during myelination. J. Neurosci. 20:8354-8364.
18. Wolswijk, G., and Balesar, R. 2003. Changes in the expression and localization of the paranodal protein Caspr on axons in chronic multiple sclerosis. Brain. 126:1638-1649.
19. Jurynczyk, M., Jurewicz, A., Raine, C.S., and Selmaj, K. 2008. Notch3 inhibition in myelin-reactive T cells down-regulates protein kinase C theta and attenuates experimental autoimmune encephalomyelitis. J. Immunol. 180:2634-2640.
20. Stidworthy, M.F., et al. 2004. Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination. Brain. 127:1928-1941.
21. Genoud, S., et al. 2002. Notch1 control of oligodendrocyte differentiation in the spinal cord. J. Cell Biol. 158:709-718.